PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 43: Articles 21001-21500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Subcutaneous implantation of gestagens. A new alternative for safe contraception. [Subkutana implantat med gestagener. Ett nytt alternativ for saker antikonception.]
  2. Subdermal contraceptive implants (editorial) [Subdermale kontraseptiewe implantings.]
  3. Success or failure? Family planning programs in the third world.
  4. Suggestion for adopting decentralised planning and target fixation method. More financial allocation for family planning programme needed.
  5. Summary report: International Workshop on Nutrition and Family Planning, conducted by Development Associates with the assistance of APROFAM and collaboration from INCAP, Guatemala, September 17-21, 1984.
  6. Superagonists of LHRH for contraception in women.
  7. Supervision in the Oyo State (Nigeria) community-based health and family planning project.
  8. Survey analysis for the guidance of family planning programs.
  9. Survey of adolescent unmet needs in family planning information and services.
  10. A survey of contraceptive sales in the Republic of Bolivia.
  11. Swedish midwives--a case of professional domination of family planning provision by women.
  12. Symptoms of emotional distress in a family planning service: stability over a four-week period.
  13. Synthesis of cyclopentylpropionic ester of norethisterone acetate as a long-acting contraceptive.
  14. A system dynamic approach to family planning and health services: the Bangladesh case.
  15. Systemic effects of oral contraceptives.
  16. Systems of households and families as an infrastructural precondition to effective family planning.
  17. Tailoring family planning programs to users' needs.
  18. Take the road of Chinese style in family planning work--35 years of family planning work in China.
  19. Taking family planning to the people.
  20. Taking the sexual, reproductive, and contraceptive histories.
  21. Teaching and learning with visual aids: a resource manual for family planning trainers and health workers in Africa and the Middle East.
  22. Technical assistance and training in family planning for Senegalese midwives.
  23. Teenage abortion patients and NHS family planning clinics: a survey of knowledge and attitudes.
  24. TFR is incapable of reflecting the situation of family planning work at a basic level.
  25. Therapeutic uses of contraceptive steroids.
  26. Third Asian and Pacific Conference perspectives on family planning, population, and development.
  27. Thirty years of family planning in India.
  28. A time model to measure contraceptive demand.
  29. Time-and dose-dependent alterations of basal and LH-RH-stimulated LH-release during treatment with various hormonal contraceptives.
  30. To have or not to have a pregnancy. Unintended pregnancy and the risks/safety of birth control methods.
  31. To increase the availability of services through emphasis on national family planning programs. [Accroitre la disponibilite des services par le biais des programmes nationaux de planification de la famille.]
  32. Tobacco, oral contraceptives and myocardial infarction in women: a case description. [Role du tabac et de la contraception oral dans l'infarctus du myocarde de la femme. Description d'un cas.]
  33. Towards a community-based approach to family planning information and education.
  34. Towards safer oral contraception.
  35. Toxic-shock syndrome and the vaginal contraceptive sponge.
  36. Traditional African religions and cultural attitudes towards family planning.
  37. Training for voluntary surgical contraception.
  38. Training program for TBA training and role in MCH and family planning: report of the Second Population Project in Egypt.
  39. Transfer of contraceptive steroids from human breast milk to infants; effect of steroids on luteinizing hormone and testosterone levels and possible biologic activity.
  40. Transferring health and family planning service innovations to the public sector: an experiment in organization development in Bangladesh.
  41. The trends in neonatal, infant and child mortality over the baseline and project periods of the Matlab Family Planning Health Services Project.
  42. Tri-Norinyl and Ortho-Novum 7/7/7--two triphasic oral contraceptives.
  43. Trip report: Honduras Contraceptive Social Marketing Program, Tegucigalpa, Honduras, June 11 - June 18, 1984.
  44. Triphasic oral contraceptives.
  45. Triquilar: a low-dose triphasic oral contraceptive.
  46. TSS reported in 4 users of contraceptive sponge.
  47. Two to tango: Haitian men and family planning.
  48. A two-year study of organised family planning services in a developing country: experiences in Bendel State of Nigeria.
  49. U.S. switch on family planning raises fear about economic development.
  50. Ultrasonic evaluation of the position of intrauterine contraceptive devices. [Ultrasonograficzna ocena umiejscowienia wewnatrzmacicznych srodkow antykoncepcyjnych.]
  51. Ultrasonically controlled removal of an intrauterine contraceptive device.
  52. Ultrasound localisation of intra-uterine contraceptive devices and associated pathology.
  53. Understanding and implementing the Party's policies on family planning accurately in an all-around way.
  54. Uneasy freedom: women's experiences of contraception.
  55. A unified social psychological model of contraceptive behavior.
  56. United States family planning programs: how should their performance be judged?
  57. Unusual displacement of an intrauterine contraceptive device. A case report.
  58. Unusual location of an intrauterine contraceptive device. [Niezwykle umiejscowienie wkladki antykoncepcyjnej.]
  59. Unwanted pregnancy as a failure of contraceptive education] [letter.
  60. Update on oral contraceptives.
  61. Urban black adolescents who obtain contraceptive services before or after their first pregnancy.
  62. Urban family planning--the Indonesian approach.
  63. Urbanization in Thailand and it implications for the family planning programme.
  64. Urbanization in Thailand and its implications for the family planning programme.
  65. US is key player in Salvador's controversial birth control plan.
  66. The use of anthropological methods and ethnolinguistic research to improve family planning and primary health care interventions, some examples from Haiti.
  67. Use of contraception in the United States, 1982.
  68. Use of family planning and maternal-child health surveys for the analysis of proximate determinants of fertility. [Uso de pesquisas de saude materno infantil e planejamento familiar para analise de determinantes proximos da fecundidade.]
  69. The use of female school teachers and imams as family planning motivators in rural Turkey. Final report: project no. 80086.
  70. Use of intra-uterine contraceptive devices in an inner city practice.
  71. Use of non-medical personnel in family planning services. [Utilizacion de personal no-medico en servicios de planificacion familiar.]
  72. Use of oral contraceptives and the incidence of breast cancer. [Forbruket av p-piller og insidens av brystkreft.]
  73. Use of oral contraceptives in women with cystic fibrosis.
  74. Use of services for family planning and infertility: United States, 1982.
  75. The use-effectiveness of tubal ligations performed in the Matlab Family Planning Health Services Project, 1978-1982.
  76. User oriented family planning research: training managers to design, implement, and utilize research for program change.
  77. Using operations research to meet the family planning needs of the urban poor in Cite Simone, Haiti.
  78. Using the focus group research technique in assessing the knowledge and attitudes of nurses about family planning.
  79. Vaginal absorption of contraceptive steroids.
  80. The vaginal contraceptive sponge.
  81. The vaginal pill and other new methods of contraception.
  82. Valued outcomes in the selection of a contraceptive method.
  83. Vasectomy within the scope of contraception. [Die Vasektomie im Rahmen der Kontrazeption.]
  84. A videotaped program for training pharmacists to conduct family planning counseling.
  85. A view of male involvement in family planning in IOR countries.
  86. Volumetric vaginal aspirator may aid in natural family planning.
  87. Voluntary surgical contraception mortality declined in Bangladesh.
  88. Volunteer characteristics and productivity in a community-based contraceptive distribution project in rural Haiti.
  89. What are the limits of birth control? [Hoe ver reiken de grenzen?]
  90. What can we expect contraceptive social marketing to accomplish?
  91. What family planning can and cannot do to limit growth.
  92. What makes the Indonesian family planning programme tick.
  93. What's new in contraception?
  94. Who attends family planning clinics?
  95. WHO Programme in Maternal and Child Health and Family Planning. Report of the second meeting of the WHO Programme Advisory Committee in Maternal and Child Health, Geneva, 21-25 November 1983.
  96. Why did you come to the clinic tonight? Motivations for adolescents' first visits to birth control clinics.
  97. Why we still need family planning clinics.
  98. Women and family planning.
  99. Women's program impact on village women's contraceptive and reproductive behavior in rural Bangladesh.
  100. Workshop on Advanced Techniques in Maternal and Child Health Care, Family Planning and MTP (December 4-7, 1979)
  101. World Conference on Voluntary Surgical Contraception, 1983.
  102. The World Fertility Survey and Contraceptive Prevalence Surveys: a comparison of substantive results.
  103. World Health Organization evaluates NORPLANT subdermal implants as effective, reversible, long-term contraceptive. News release.
  104. Young men: their attitudes towards sexuality and birth control.
  105. Youth and contraception education. A study among pupils of post-compulsory schools in the Bergen area. [Ungdom og prevensjonsopplysning. En undersokelse blant elever ved vidergaende skoler i Bergen og omegn.]
  106. Clinical use of combined contraceptive preparations of Hungarian manufacture. [Klinicheskoe primenenie nekotorykh kombinirovannykh protivo-zachatochnykh preparatov vengerskogo proizvodstva.]
  107. A comparative multicentre study on a triphasic, and a fixed low-dose oral contraceptive combination [abstract]
  108. Comparative trials of low-dose combined oral contraceptives.
  109. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices.
  110. Oral contraceptive use and the occurrence of pituitary prolactinoma.
  111. Oral contraceptives and breast cancer [letter]
  112. Oral contraceptives and breast cancer: final report of an epidemiological study.
  113. Prolactin response to dopamine synthesis inhibition using monoiodotyrosine in subjects on oral contraceptives and patients with pathological hyperprolactinemia.
  114. A prospective cohort study of oral contraceptives and cancer of the endometrium.
  115. A prospective multicentre trial of the ovulation method of natural family planning. III. Characteristics of the menstrual cycle and of the fertile phase.
  116. Providing maternal and child health-family planning services to a large rural population: results of the Bohol Project, Philippines.
  117. A randomized prospective study of the metabolic effects of four low-estrogen oral contraceptives.
  118. Reasons for discontinuing contraception among women in Bangkok.
  119. The effect of combined oral contraceptive steroids on the gonadotropin responses to LH-RH in lactating women with regular menstrual cycles resumed.
  120. The effect of cotrimoxazole on oral contraceptive steroids in women.
  121. Effect of oral contraception by progesterone pill on lipids and glucose metabolism.
  122. Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels.
  123. Effects of combined oral contraceptive steroids on pituitary-ovarian function during the menstrual cycle of lactating women.
  124. Effects of contraceptive vaginal ring treatment on vaginal bacteriology and cytology.
  125. The effects of intrauterine contraceptive devices on the ultrastructure of the endometrium in relation to bleeding complications.
  126. The effects of oral contraceptives on respiration.
  127. Effects of synthetic steroid contraceptives on biliary lipid composition of normal Mexican women.
  128. Abortion and contraception in Poland.
  129. The acceptability of a progestagen-only contraceptive during breast-feeding.
  130. Actinomyces Israelii in the genital tract of women with and without intra-uterine contraceptive devices.
  131. Actinomycotic infection of endometriosis caused by intrauterine contraception. [Zur aktinomykotischen Infektion von Endometriosen bei intrauteriner Kontrazeption.]
  132. Behavioural patterns in women requesting postcoital contraception.
  133. Blood prolactin levels: influence of age, menstrual cycle and oral contraceptives.
  134. Breast cancer and oral contraceptives [letter]
  135. Breast feeding and contraception. [Szoptatas es fogamzasgatlas.]
  136. Budd-Chiari syndrome complicated with DIC in connection with the use of oral contraceptive. [DIC-kel szovodott Budd-Chiari-szindroma oralis antikoncipiens szedese kapcsan.]
  137. Case-control study of rheumatoid arthritis and prior use of oral contraceptives.
  138. Changes in plasma vitamin A in lactating and non-lactating oral contraceptive users.
  139. Clinical evaluation of an improved injectable microcapsule contraceptive system.
  140. Clinical experience with a low-dose contraceptive agent: European studies.
  141. Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America.
  142. Contraception, marital fertility, and breast-feeding in the Yemen Arab Republic.
  143. Contraceptive failure and continuation among married women in the United States, 1970-75.
  144. Contraceptive knowledge, contraceptive use, and pregnancy risk experience among young Manawatu women.
  145. Contraceptive use and program development: new information from Indonesia.
  146. Contraceptive users in rural Bangladesh: a time trend analysis.
  147. Controlled release of contraceptive steroids from biodegradable poly (ortho esters)
  148. The cost of contraception.

     

  149. Determinants of national family planning effort.
  150. The effect of a biodegradable contraceptive capsule (Capronor) containing levonorgestrel on gonadotropin, estrogen, and progesterone levels.
  151. The effects of three different regimens of oral contraceptives and three different intrauterine devices on the levels of hemoglobin, serum iron and iron binding capacity in anemic women.
  152. Effects of two low-dose oral contraceptives on serum lipids and lipoproteins: differential changes in high-density lipoprotein subclasses.
  153. Evidence of prior pelvic inflammatory disease and its relationship to Chlamydia trachomatis antibody and intrauterine contraceptive device use in infertile women.
  154. Our experience with the clinical trial of postinor--an oral hormonal preparation for postcoital contraception. [Nashiiat opit ot klinichnoto izpitvane na postinor--khormonalen oralen preparat za postkoitalna kontraseptsiia.]
  155. Ovarian function, bleeding control and serum lipoproteins in women using contraceptive vaginal rings releasing five different progestins.
  156. Perceptions of family planning among rural Kenyan women.
  157. The phasic approach to oral contraception: the triphasic concept and its clinical application.
  158. Pituitary adenomas and oral contraceptives: a multicenter case-control study.
  159. Plasma antithrombin III and inhibitors of fibrinolysis are not influenced by oral contraceptives in diabetic women [abstract]
  160. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
  161. Factors associated with actinomyces-like organisms on Papanicolaou smear in users of intrauterine contraceptive devices.
  162. Family history, oral contraceptive usage, and breast cancer.
  163. Family planning among the urban poor: sexual politics and social policy.
  164. Family planning clinic services in the United States, 1981.
  165. Family planning field research projects: balancing internal against external validity.
  166. Fertility regulation in nursing women: III. Short-term influence of a low-dose combined oral contraceptive upon lactation and infant growth.
  167. Fertility regulation in nursing women: IV. Long-term influence of a low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth.
  168. Fibrinolytic activity in the walls of foot veins in women using combined contraceptive pills.
  169. Five years' experience of intrauterine contraception with the Nova-T and the Copper-T-200.
  170. Fragmentation of intra-uterine contraceptive devices during their extraction (author's transl) [Fragmentation von Intrauterinpessaren als Komplikation bei der Extraktion.]
  171. Frequency of non-hormonal contraception around conception and association with congenital malformations in offspring.
  172. Glycohemoglobin (Hb A1) levels in oral contraceptive users.
  173. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
  174. Impact of accessibility of contraceptives on contraceptive prevalence in Guatemala.
  175. Infant and child survival and contraceptive use in the closed pregnancy interval.
  176. The influence of oral contraceptives on activated factor X inhibitor (XaI)-activity: a prospective study.
  177. The influence of psychological and situational factors on the contraceptive behavior of single men: a review of the literature.
  178. Lack of correlation between contraceptive pills and Down's syndrome.
  179. Male contraception: the effect of d-norgestrel and testosterone enanthate on spermatogenesis--ultrastructural characteristics.
  180. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effect of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis.
  181. Natural family planning: a comparison of continuers and discontinuers.
  182. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
  183. Norethindrone in serum after use of an oral contraceptive containing norethindrone acetate.
  184. Norethisterone levels in maternal serum and milk after intramuscular injection of norethisterone oenanthate as a contraceptive.
  185. On the history of contraception and a look to the future (author's transl) [Zur Geschichte der Kontrazeption und ein Blick in die Zukunft.]
  186. Oral contraception with a low dose triphasic pill. [Orale Schwangerschaftsverhutung mit einem niedrig dosierten Dreistufenpraparat.]
  187. Oral contraceptive steroids do not promote the development or growth of prolactinomas.
  188. Plasma lipids in women using progestogen-only oral contraceptives.
  189. Poly(DL-lactide-co-glycolide)/Norethisterone microcapsules: an injectable biodegradable contraceptive.
  190. Positive effects of oral contraceptives. [Effetti positivi dei contraccettivi orali.]
  191. Post coital contraception--a study.
  192. Postabortal contraception with norethisterone enanthate injections.
  193. Postcoital contraception. [Postkoital'naia kontraseptsiia.]
  194. Postmolar trophoblastic disease in women using hormonal contraception with and without estrogen.
  195. Postpartum lactational amenorrhoea as a means of family planning in the Sudan: A study of 500 cases.
  196. Prednisolone disposition and protein binding in oral contraceptive users.
  197. Presence of the "Beaumont" protein in serum of oral contraceptive users.
  198. Reduced plasminogen activator content of the endometrium in oral contraceptive users.
  199. Relationship of oral contraceptive estrogen dose to age.
  200. Relationship of oral contraceptives and the intrauterine contraceptive devices to the regression of concentrations of the beta subunit of human chorionic gonadotropin and invasive complications after molar pregnancy.
  201. Repeat abortion-seeking behavior in Queensland, Australia: knowledge and use of contraception and reasons for terminating the pregnancy.
  202. Restovar--a new low-dose, combined oral contraceptive. Effects on serum proteins, free testosterone and clinical efficacy [abstract]
  203. A review of the current status in male contraceptive studies.
  204. Serum lipids and proteins during treatment with a new oral contraceptive combination containing desogestrel.
  205. The short-term effects of a low-dose oral contraceptive on glucose metabolism, plasma lipids and blood clotting factors.
  206. Side effect of hormonal contraception: porphyria cutanea tarda (author's transl) [Mogliche Nebenwirkung der hormonalen Kontrazeption: Porphyria cutanea tarda.]
  207. Side effects of danazol compared with an ethinyloestradiol/norgestrel combination when used for postcoital contraception.
  208. Side effects of oral contraceptives. [Pobochnye de istviia oral'nykh kontvatseptivov.]
  209. Socioeconomic status and use of contraceptives among unmarried primigravidas in Cape Town.
  210. Somatic tissue responses of male rhesus monkeys treated with a contraceptive steroid formulation.
  211. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
  212. Synthesis and release of gonadotropins: effect of an oral contraceptive.
  213. Systemic changes during the use of hormonal contraceptives. [Izuchenie sistemnykh izmenenii pri primenenii gormonal'nykh kontraseptivov.]
  214. Testis function in rhesus monkeys treated with a contraceptive steroid formulation.
  215. Thirty years of the Indian Family Planning Program: past performance, future prospects.
  216. Three-year experience with NORPLANT subdermal contraception.
  217. Thyroid function during treatment with a new oral contraceptive combination containing desogestrel.
  218. Ultrasonic measurement of ovarian follicles during chronic LRH agonist treatment for contraception.
  219. Urinary concentrations of steroid glucuronides in women taking oral contraceptives.
  220. User's perception of the contraceptive vaginal ring: a field study in Brazil and the Dominican Republic.
  221. Values clarification as a technique for family planning education.
  222. Sources of population and family planning assistance./Fontes de assistencia populacional e de planejamento familiar./Fuentes de asistencia de poblacion y planificacion familiar./Sources d'assistance internationale dans le domaine de la population et du planning familial.
  223. Coagulation studies in women using combination type of oral contraceptives.
  224. Coercion in a soft state: the family-planning program of India. Part 2: the sources of coercion.
  225. Cold urticaria and an oral contraceptive [letter]
  226. Collagen sponge as vaginal contraceptive barrier: critical summary of seven years of research.
  227. Colonialism, Catholicism, and contraception: a history of birth control in Puerto Rico.
  228. Combined contraceptives. [La contraception oestroprogestative.]
  229. Communicating about voluntary surgical contraception.
  230. Communication about voluntary surgical contraception: "why and how".
  231. Communication factors and their influence on family planning behaviour among non-adopters.
  232. Communication in family planning: evaluation of four states in the Northeast. [Comunicacao em planejamento familiar: uma avaliacao em quatro estados do Nordeste.]
  233. Communication's support for family planning: role of different media and some policy implications.
  234. Communique of the State Family Planning Commission on a nationwide fertility sampling survey of every person per thousand.
  235. Community based contraceptive distribution in Haiti: some operations research issues.
  236. Community characteristics and contraception in rural Costa Rica, 1982. [Caracteristicas de la domunidad y anticoncepcion en el area rural de Costa Rica, 1982.]
  237. Community family planning clinics. An evaluation.
  238. Community forum 1: family planning. Boy or girl--is it possible to choose?
  239. Comparative analysis of fertility, breastfeeding, and contraception: a dynamic model.
  240. The comparative politics of birth control: determinants of policy variation and change in the developed nations.
  241. Comparative study of the biochemical effects of combined estrogen/progestogen oral contraceptives containing less than 50 micrograms of estrogen.
  242. A comparative study of two estrogen dosages in combined oral contraceptives among Sudanese women.
  243. Comparative trial of the contraceptive sponge and diaphragm: a preliminary report.
  244. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
  245. Comparison of haematological indices between women of four ethnic groups and the effect of oral contraceptives.
  246. A comparison of responses to adolescent-oriented and traditional contraceptive programs.
  247. A comparison of the efficacy of two vaginal creams for vulvovaginal candidiasis, and correlations with the presence of Candida species in the perianal area and oral contraceptive use.
  248. Comparison of the frequency of muscle pain associated with suxamethonium in pre- and post-ovulatory women and in those taking a combined oral contraceptive pill.
  249. Comparison of the metabolic effects of desogestrel and of levonorgestrel in low-dose oestrogen oral contraceptives.
  250. Complications in 1,717 women in whom an intrauterine device was used for contraception. [Komplikacije u 1717 zena u kojih je primenjen intrauterusni ulozak u cilju antikoncepcije.]
  251. Complications of contraception.
  252. Comprehensive fertility awareness and natural family planning (client manual)
  253. Oral contraceptive use and prevalence of infection with Chlamydia trachomatis in women (author's transl) [Emploi des contraceptifs oraux et frequence de l'infection a chlamydia trachomatis chez la femme.]
  254. Oral contraceptives and ascorbic acid metabolism [letter]
  255. Oral contraceptives and benign breast disease.
  256. Oral contraceptives and breast cancer [letter]
  257. Oral contraceptives and breast cancer [letter]
  258. Oral contraceptives and breast cancer [letter]
  259. Oral contraceptives and breast cancer rates [letter]
  260. Oral contraceptives and breast cancer.
  261. Oral contraceptives and cancer [letter]
  262. Oral contraceptives and cancer [letter]
  263. Oral contraceptives and cancer [letter]
  264. Oral contraceptives and cancer [letter]
  265. Oral contraceptives and cancer [letter]
  266. Oral contraceptives and cancer [letter]
  267. Oral contraceptives and cancer [letter]
  268. Oral contraceptives and cancer [letter]
  269. Oral contraceptives and cancer [letter]
  270. Oral contraceptives and cancer [letter]
  271. Oral contraceptives and cancer. [P-piller og cancer.]
  272. Oral contraceptives and cervical cancer [letter]
  273. Oral contraceptives and cervical cancer [letter]
  274. Oral contraceptives and cervical cancer [letter]
  275. Oral contraceptives and cervical cancer [letter]
  276. Oral contraceptives and mortality from circulatory system diseases: an epidemiologic study in Taiwan.
  277. Oral contraceptives and neoplasia.
  278. Oral contraceptives and ovarian cancer [letter]
  279. Oral contraceptives and ovarian cancer [Reply to letter of Casagrande, Pike and Henderson] [letter]
  280. Oral contraceptives and postoperative venous thrombosis [letter]
  281. Oral contraceptives and rheumatoid arthritis [letter]
  282. Oral contraceptives and rheumatoid arthritis [letter]
  283. Oral contraceptives and the risk of cancer [editorial]
  284. Project progress report II: Integrated Project of Family Planning and Parasite Control in Oeiras, Brazil (executed by BEMFAM)
  285. Project progress report III: Integrated Family Planning and Parasite Control Project of Sao Paulo, Brazil (executed by CMI-PF)
  286. Project progress report IV: Integrated Family Planning and Parasite Control Project of Colombia.
  287. Project progress report V: the Integrated Project of Family Planning, Parasite Control and Nutrition in Indonesia.
  288. Project progress report VI: the Integrated Family Planning and Parasite Control and Nutrition Project in Korea.
  289. Project progress report VII: Integrated Parasite Control and Family Planning Project of Malaysia.
  290. Project progress report VIII: experiences of the Integrated Family Planning and Parasite Control Project conducted by the Population and Community Development Association (PDA) of Thailand.
  291. Project summary: promotion of family planning and population development in the northeastern region of Thailand.
  292. Prolactin plasma levels and oral contraceptives at low dosage.
  293. A prospective study of women included in the two contraceptive prevalence studies undertaken in Costa Rica, 1978-1981. [Estudio prospectivo de las mujeres entrevistadas en dos encuestas de prevalencia anticonceptiva, Costa Rica, 1978-1981.]
  294. Prospects for a future family planning program--what contraceptive techniques are feasible at the primary health care level and who should apply them: barrier methods.
  295. Prospects of oral contraceptives. [Perspectivas actuales de los contraceptivos orales.]
  296. The providers and the users of contraception.
  297. Providing contraceptive care on a college campus.
  298. The provision of a postcoital contraception service.
  299. Psychological attitudes of Algerian women to contraception (author's transl) [Psychologie de la femme algerienne devant les methodes contraceptives.]
  300. Psychological correlates of contraceptive behavior in late adolescent women.
  301. Psychological issues in contraceptive sterilisation.
  302. Psychological issues resulting from the development of new male contraceptives [letter]
  303. Puerto Rican Family Welfare Association: the woman and family planning.
  304. A qualitative study of male contraceptive attitudes in St. Kitts-Nevis.
  305. Quantitative evaluation of the spermicidal potencies of vaginal contraceptives with a transmembrane migration method.
  306. Questions to Solomon Sobel, Product Development and New Drug Approval, Metabolic and Endocrine Drugs, Food and Drug Administration, regarding safety of "Today" contraceptive sponge] [letter.
  307. A randomized trial of vas occlusion versus vasectomy for male contraception.
  308. The rationales for voluntary surgical contraception.
  309. Reactions between medications and estroprogestatives used in oral contraception. [Interferences entre medicaments et estroprogestatifs utilises en contraception orale.]
  310. Reasons for discontinuation of Depo Provera at a family planning clinic.
  311. Effect of a combined oral contraceptive on lactation and growth of the infant. [Influencia de un anticonceptivo oral combinado sobre la lactancia y el crecimiento del nino.]
  312. The effect of administration family planning policy on maternal and child health.
  313. Effect of an intrauterine contraceptive device on the singing voice. [O vliianii vnutrimatochnykh kontratseptivnykh sredstv na pevcheskii golos.]
  314. Effect of an oral contraceptive on serum phosphohexose isomerase activity [letter]
  315. The effect of child mortality on contraceptive use and fertility in Colombia, Costa Rica and Korea [tables]
  316. The effect of child mortality on contraceptive use and fertility in Colombia, Costa Rica and Korea.
  317. Effect of hormonal contraceptives on cardiovascular function. [Vliianie gormonal'nykh kontratseptivov na funktsional'noe.]
  318. Effect of long-term use of composite steroid contraceptives on serum lipids in women.
  319. Effect of low dose oral contraceptive on lactation pattern in Egyptian women.
  320. The effect of oral contraceptive therapy and of pregnancy on serum folate levels of rural Sri Lankan women.
  321. The effect of oral contraceptives and exercise on hemostatic and fibrinolytic mechanisms in trained women.
  322. The effect of oral contraceptives in Malaysians: 1. iron metabolism and erythropoiesis.
  323. The effect of oral contraceptives in Malaysians: II. folate and vitamin B12 metabolism.
  324. Effect of oral contraceptives on lipid and lipoprotein metabolism]
  325. The effect of oral contraceptives on sister chromatid exchange, blast transformation, mitotic index and micronuclei formation.
  326. Effect of orange juice, folic acid, and oral contraceptives on serum folate in women taking a folate-restricted diet.
  327. Effect of synthetic oestrogens and progestagens in oral contraceptives on bile lipid composition.
  328. The effect of the male contraceptive agent Gossypol on human lymphocytes in vitro: traditional chromosome breakage, micronuclei, sister chromatid exchange, and cell kinetics.
  329. The effectiveness of barrier methods of contraception with and without spermicide. [Efficacite des methodes contraceptives vaginales mecaniques avec ou sans spermicide.]
  330. Effectiveness of publications in family planning program.
  331. Effects and side effects of hormonal contraceptives in the region of the nose, throat and ear. [Wirkung und Nebenwirking hormonaler Antikonzeptiva in Bereich von Nase, Hals und Ohr.]
  332. The effects of demographic, socioeconomic and health factors on family size and the use of birth control methods: a case of a major developing country with high rate of population growth.
  333. Effects of menstruation and contraceptive pill on the performance of physical education students.
  334. Effects of oral contraceptive steroids on acetaminophen metabolism and elimination.
  335. Effects of oral contraceptives on serum lipid profiles of women runners.
  336. The 'Don't forget your umbrella' contraceptive.
  337. 1981 census of India: some implications for family planning.
  338. Abortion and contraception in 1982. Annual report from the Permanent Registration of Abortion, supplemented by various research data relating to the use of contraceptives in the Netherlands. [Abortus en anticonceptie anno 1982. Jaarverslag van de Permanente Registratie Abortus, aangevuld met diverse onderzoeksgegevens betreffende anticonceptiegebruik in Nederland.]
  339. Abortion, contraception, and fertility in Quebec and Canada. [L'avortement, la contraception et la fecondite au Quebec et au Canada.]
  340. Abstract on population and family planning research. [Abstrak hasil penelitian bidang kependudukan keluarga berencana.]
  341. Acceptance and non-acceptance of birth control methods and associated facts in rural areas of Midnapur district of West Bengal.
  342. The acceptance of organized family planning programs by women in need in the United States.
  343. Access to family planning at the grass-root level: how to overcome current constraints. Introduction to working group discussions.
  344. Achievements of the national family planning publicity month.

     

  345. Actinomycosis infection associated with intrauterine contraceptive devices.
  346. Administrative culture and organization: state level variance in the performance of the Malaysian National Family Planning Program.
  347. Adolescent contraception. Review and recommendations.
  348. Adolescent contraception: summary and recommendations.
  349. Adolescent sexuality, sex education and family planning: a selected bibliography for Latin America. [Sexualidad adolescente, educacion sexual, y planificacion familiar: seleccion bibliografica para America Latina.]
  350. Adolescents and contraception today. [Adolescents et contraception aujourd'hui.]
  351. Adolescents' communication styles for learning about birth control from mass media.
  352. Adolescents' preference of source to obtain contraceptive information.
  353. Adolescents, sex, and contraception.
  354. Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol.
  355. Advances in oral contraception. Questions and answers.
  356. Again on postcoital contraception. [Znovu o postkoitalni antikoncepci.]
  357. Agreement between women's histories of oral contraceptive use and physician records.
  358. The Alexandria project: training of trainers in family planning.
  359. Alternatives to adolescent pregnancy: review of contraceptive literature.
  360. The American Academy of Natural Family Planning.
  361. Aminopyrine breath test in women on oral contraceptives.
  362. Analysis of input-output relationship for studying the efficiency of the family planning programme in Thailand.
  363. Analysis of surface deposits on intrauterine contraceptive devices.
  364. Anatomy of the complications (side effects) of intrauterine contraceptive device (IUCD)
  365. Anemias in pregnancy following hormonal contraception. [Schwangerschaftsanamie nach vorangegangener hormoneller Kontrazeption.]
  366. Angiographic findings of vasculitis in four women with acute cerebrovascular accidents while taking oral contraceptives. [Hallazgos angiograficos de vasculitis en 4 casos de accidentes cerebrovasculares agudos (ACVA) durante la toma de anticonceptivos.]
  367. Annual report on family planning acceptors Sri Lanka, 1981.
  368. Annual report, 1982. Maternal-child health. Family planning. [Rapport annuel, annee 1982. Protection materno-infantile. Plantification familiale.]
  369. Another look at the costs and benefits of government expenditures for family planning programs.
  370. Another look at the costs and benefits of government expenditures for family planning programs. A reply.
  371. Antigens for contraceptive vaccination and the effects of immunization.
  372. Antithrombin III and platelets during the normal menstrual cycle and in women receiving oral contraceptives low in oestrogen.
  373. Apparent oral contraceptive failure associated with antibiotic administration.
  374. The appropriateness of modern contraceptive technology for developing countries.
  375. Arterial complications of oral contraception. [Les accidents arteriels de la contraception par oestro-progestatifs.]
  376. Ascorbic acid and oral contraceptive agent use [letter]
  377. ASEAN directory of demography and family planning research and training institutions.
  378. Asian Family Planning Program Determinants Project. Preliminary report presentation, Washington, D.C., August 1, 1983 [tables]
  379. Assessing the impact of copayment on family planning services: a preliminary analysis in California.
  380. An assessment of management contribution to the Family Planning and Population Programme in Sri Lanka.
  381. Association for population/family planning libraries and information centers-international (APLIC)
  382. Attitude to be taken with the adolescent requesting contraception. [Attitude a adopter face a une adolescente faisant une demande de contraception.]
  383. Attitudes to contraception in women seeking termination of pregnancy.
  384. Attitudes to sexuality and contraception in Eire.
  385. Attitudes toward abortion and contraception among Nigerian secondary school girls.
  386. Attitudes toward family and family planning in the pre-Saharan Maghreb.
  387. Attitudes toward family planning of black medical students at Meharry Medical College.
  388. Australian family planning surveys: some problems of comparability.
  389. Author's reply to letter from the editors of Population Reports commenting on "A One-Sided View of Natural Family Planning"] [letter.
  390. Availability of family planning services.
  391. Awareness and acceptance of family planning among rural development functionaries.
  392. Background factors of defective contraception in abortion-seeking patients. [Bakgrundsfaktorer till bristande antikonception hos abortpatienter.]
  393. Background to the Contraceptive Prevalence Survey (CPS) in Sri Lanka.
  394. Bangladesh Contraceptive Prevalence Survey--1981.
  395. Barrier contraceptives.
  396. Basic processes and principles for population/family planning communication.
  397. Before the velvet curtain: the Connecticut contraceptive cases as a study in constitutional law and Supreme Court behavior.
  398. Beliefs, attitudes, intentions and contraceptive behavior of college students.
  399. Benign hepatic tumor and oral contraceptives.
  400. Benign liver tumors following long-term use of oral contraceptives. 2. Diagnosis and therapy. [Benigne Lebertumoren nach Langzeiteinnahme oraler Kontrazeptiva. II. Klinische Diagnostik und Therapie.]
  401. Benign liver tumors following long-term use of oral contraceptives. I. Results of image-providing diagnostic procedures in intra-operative accidentally discovered tumors. [Benigne Lebertumoren nach Langzeiteinnahme oraler kontrazeptiva. I. Ergebnisse bildgebender diagnostischer Verfahren bein zufallig intraoperative entdeckten Tumoren.]
  402. Benzalkonium chloride--a new vaginal contraceptive.
  403. Bibliography on family planning in Thailand, (1963-1983)
  404. Bibliography on population and family planning research, 1961-1981. [Bibliografi penelitian bidang KKB, 1961-1981.]
  405. A billion and counting: family planning campaigns and policies in the People's Republic of China.
  406. Birth control and the Roman Catholic Church.
  407. Birth control in a culture of changing sex roles: the NFP experience.
  408. Birth control in overseas countries. [La regulation de la fecondite outre-mer.]
  409. Birth control methods and their effects on fertility.
  410. Birth control socialization: how to avoid discussing the subject.
  411. Birth control techniques in China.
  412. Birth control technologies: prospects by the year 2000.
  413. Birth control to the rescue in developing countries [letter]
  414. Birth control, socialism and feminism in the United States.
  415. Birth-control decisions: hidden factors in contraceptive choices.
  416. Bleeding patterns with long-acting steroidal contraceptives.
  417. Blood levels of levonorgestrel in women following vaginal placement of contraceptive pills.
  418. Bolivia: the working class and family planning.
  419. Botswana. Government aims to extend family planning services.
  420. Botswana: family planning myths and beliefs.
  421. Breast cancer and oral contraceptive use: a case-control study.
  422. Breast cancer and oral contraceptives [letter]
  423. Breast cancer and oral contraceptives [letter]
  424. Breast cancer and oral contraceptives [letter]
  425. Breast cancer and oral contraceptives [letter]
  426. Breast cancer and oral contraceptives: reply to critics [letter]
  427. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.
  428. Breast feeding as a method of contraception? 1. The epidemiology of breast feeding in a suburban region of Tunis. [L'allaitement maternel, moyen de contraception? 1ere partie: epidemiologie de l'allaitement maternel dans une zone sub-urbaine de Tunis.]
  429. Breast-feeding and contraception [letter]
  430. Breast-feeding and family planning policy.
  431. Breast-feeding, contraception and birth spacing in Mali.
  432. Breast-feeding, family planning, post partum return of menstruation and sexual activity--the Nigerian experience.
  433. Breastfeeding and oral contraceptives: Tasmanian survey.
  434. Breastfeeding as a means of contraception.
  435. Breastfeeding, supplements, contraception, and infant growth in low-income areas of Mexico [tables]
  436. Breastfeeding, supplements, contraception, and infant growth in rural and low-income urban areas of Mexico [draft]
  437. Budd-Chiari syndrome associated with oral contraceptive steroids. Review of treatment of 47 cases.
  438. Budd-Chiari syndrome, liver cell adenoma and polycythemia following contraceptives. [Budd-Chiari-Syndrom, Leberzelladenome und Polyglobulie nach Ovulationshemmern.]
  439. Buddhist-Moslem differentials in fertility and family planning in Thailand with special emphasis on the southern region: an analysis of data from the 1975 Survey of Fertility in Thailand.
  440. The Canadian birth control movement on trial, 1936-1937.
  441. Caribbean Contraceptive Social Marketing Project: initial marketing plan. Chapters V-XII.
  442. Carotid-dural arteriovenous fistual during use of an oral contraceptive.
  443. Case of ectopic pregnancy after postcoital contraception with ethinyloestradiol-levonorgestrel.
  444. Case of genital tract intolerance to a contraceptive intrauterine device. [Przypadek braku tolerancji narzadu rodnego na zalozona wkladke antykoncepcyjna.]
  445. Case study I: qualitative development of the Integrated Family Planning, Nutrition and Parasite Control Project in Sri Lanka.
  446. Case study II. Community-based health care system under the Integrated Family Planning and Parasite Control Project of Nepal.
  447. Case study IV. The Integrated Project on Family Planning, Parasite Control and Nutrition in the Philippines.
  448. The case study of legalizing voluntary surgical contraception in Turkey.
  449. Central Mindanao: selling family planning informally.
  450. Cerebral ischemia and combined contraceptives. The role of immunologic mechanisms: 2 cases. [Ischemie erebrale et oestroprogestatifs de synthese. Role des mechanisms immunologiques: a propos de deux case.]
  451. Cerebrovascular complications of oral contraceptives.
  452. Cervical and vault contraceptive caps. How they work and how to use them.
  453. Cervical cancer and oral contraceptives [letter]
  454. Cervical cancer in association with intrauterine contraceptive devices.
  455. The cervical cap: effectiveness as a contraceptive.
  456. Cervical choriocarcinoma associated with an intrauterine contraceptive device: a case report.
  457. Cervical cytological screening for users of oral contraceptives [letter]
  458. Changes in attitudes toward contraceptives concomitant with instructional activities in physiology.
  459. Changes in Yantai area brought about by family planning.
  460. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
  461. Changes of serum lipoproteins in women taking combined oral contraceptives. [Modificaciones de las lipoprotienas sericas en mujeres tratadas con anticonceptivos orales combinados.]
  462. Changing pattern of family planning acceptors.
  463. Characteristics of family planning clients in Bangladesh.
  464. Characteristics of oral contraceptive buyers in Rio de Janeiro (experimental survey) [Caracteristicas das compradoras de anovulatorios no Rio de Janeiro (pesquisa experimental)]
  465. The characteristics of population growth of the Dongxiang nationality and the necessity of carrying out family planning.
  466. Child and maternal health services in rural India: the Narangwal experiment. Vol. 2. Integrated family planning and health care.
  467. Child health and family planning [editorial]
  468. China's first family planning publicity month.
  469. China: population policy and family planning practice.
  470. Choice of contraception for the diabetic woman. [Choix d'une contraception chez la femme diabetique.]
  471. Choosing a birth control method that's right for you.
  472. Choosing contraceptive steroids and doses.
  473. Choreas induced by contraceptives. [Coreas por anticonceptivos.]
  474. Christians and the state policy of family planning--attitudinal change?
  475. Chronic (24 month) intravaginal safety study of nonoxynol-9 contraceptive foaming suppository in rats with a three-month interim sacrifice.
  476. Chronic schizophrenic women's attitudes toward sex, pregnancy, birth control, and childrearing.
  477. Cigarette smoking, oral contraceptives and lipidogenesis in women. [Cigarettes, contraceptifs et lipidogenese chez la femme.]
  478. Clinic and contraceptive use of adolescent clients.
  479. Clinical data on the use of current oral contraceptives. [Klinicheskie dannye primeneniia sovremennykh ora'nykh kontratseptivov.]
  480. Clinical effects of NORPLANT subdermal implants for contraception.
  481. Clinical experience with triphasic oral contraceptive ('Trinordiol') in young women.
  482. Clinical pharmacokinetics of oral contraceptive steroids.
  483. Clinical study of a long-acting progestogen contraceptive 3-cyclopentyl propionate of megestrol acetate (progestin no. 1)
  484. Comprehensive fertility awareness and natural family planning. Northwest NFP Services: Talks I-IV.
  485. Comprehensive overview of intrauterine contraceptive device (IUCD)
  486. Compulsory birth control and fertility measures in India: a simulation approach.
  487. A Computerized sample registration system for monitoring household demographic dynamics, service operations, and contraceptive use--Part I. the demographic data component.
  488. Computers and contraception: strange bedfellows? Contraception education survey.
  489. Concerning family planning in Madagascar. [A propos de la planification familiale a Madagascar.]
  490. A connection between parturition, hormonal contraception and the incidence of varices. [Povezanost poroda i hormonske kontracepcije s pojavom varica.]
  491. Conservation and contraception.
  492. Contraception and blood copper levels. [Contraception et cupremie.]
  493. Contraception and fertility in the Netherlands.
  494. Contraception and religiousness in a general practice population in Israel.
  495. Contraception and sexuality. [Anticoncepcion y sexualidad.]
  496. Contraception and sports. [Contraception--sports.]
  497. Contraception and teenagers.
  498. Contraception and voluntary termination of pregnancy in public hospitals. Circular DGS/2A No. 12-82, October 12, 1982. [Contraception et I.V.G. dans les etablissements hospitaliers publics. Circulaire DGS/2A No 12-82 du 12 october 1982.]
  499. Contraception for adolescents.
  500. Contraception for the older woman.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.